Highly Potent Active Pharmaceutical Ingredients (HPAPI) facilities present unique challenges in construction, operation, and maintenance. Each process step, though facilitated by gravity or vacuum, carries inherent risks related to potency, explosion potential, and product characteristic alterations.
Containment Challenges
HPAPI handling requires specialized containment solutions to protect operators from exposure to highly potent compounds while maintaining product integrity. Dow Engifab's isolator systems are designed to address these challenges through robust engineering and advanced containment technologies.
Process Safety
The risk of explosion and product characteristic changes during API processing necessitates carefully designed equipment with appropriate safety measures. Dow's systems incorporate features that mitigate these risks while ensuring efficient process flow.
Scale Flexibility
Dow provides containment solutions that can be scaled from R&D operations to commercial production, allowing pharmaceutical manufacturers to maintain consistent containment strategies throughout the product development lifecycle.
Dow Engifab's API solutions are engineered to meet the stringent requirements of modern pharmaceutical manufacturing, providing safe, efficient, and compliant systems for handling highly potent compounds.
